178 related articles for article (PubMed ID: 36768138)
1. Gliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In Vitro.
Koch B; Fuhrmann DC; Schubert R; Geiger H; Speer T; Baer PC
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768138
[TBL] [Abstract][Full Text] [Related]
2. No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro.
Baer PC; Koch B; Freitag J; Schubert R; Geiger H
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936266
[TBL] [Abstract][Full Text] [Related]
3. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
[TBL] [Abstract][Full Text] [Related]
4. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition.
Das NA; Carpenter AJ; Belenchia A; Aroor AR; Noda M; Siebenlist U; Chandrasekar B; DeMarco VG
Cell Signal; 2020 Apr; 68():109506. PubMed ID: 31862399
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin Prevents High-Glucose-Induced Cellular Senescence in Renal Tubular Epithelial Cells.
Eleftheriadis T; Pissas G; Filippidis G; Efthymiadi M; Liakopoulos V; Stefanidis I
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555751
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
[TBL] [Abstract][Full Text] [Related]
7. Identification of circular RNAs and functional competing endogenous RNA networks in human proximal tubular epithelial cells treated with sodium-glucose cotransporter 2 inhibitor dapagliflozin in diabetic kidney disease.
Song Y; Guo F; Liu Y; Huang F; Fan X; Zhao L; Qin G
Bioengineered; 2022 Feb; 13(2):3911-3929. PubMed ID: 35129424
[TBL] [Abstract][Full Text] [Related]
8. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels.
Cai A; Shen J; Yang X; Shao X; Gu L; Mou S; Che X
Front Immunol; 2023; 14():1205834. PubMed ID: 38022502
[TBL] [Abstract][Full Text] [Related]
10. Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy.
Kim DH; Yoo TH; Lee SH; Kang HY; Nam BY; Kwak SJ; Kim JK; Park JT; Han SH; Kang SW
Yonsei Med J; 2012 Nov; 53(6):1165-75. PubMed ID: 23074118
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
Makaro A; Świerczyński M; Pokora K; Sarniak B; Kordek R; Fichna J; Salaga M
Inflammopharmacology; 2024 Feb; 32(1):377-392. PubMed ID: 37086302
[TBL] [Abstract][Full Text] [Related]
12. The tubular hypothesis of nephron filtration and diabetic kidney disease.
Vallon V; Thomson SC
Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease.
Farias RS; Silva-Aguiar RP; Teixeira DE; Gomes CP; Pinheiro AAS; Peruchetti DB; Caruso-Neves C
Eur J Pharmacol; 2023 Mar; 942():175521. PubMed ID: 36681317
[TBL] [Abstract][Full Text] [Related]
14. Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells.
Yiu WH; Wong DW; Chan LY; Leung JC; Chan KW; Lan HY; Lai KN; Tang SC
PLoS One; 2014; 9(2):e88894. PubMed ID: 24586431
[TBL] [Abstract][Full Text] [Related]
15. [Empagliflozin in the elderly].
Berrut G; Boureau AS; Trochu JN; Genet B; de Decker L; Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2021 Jun; 19(2):137-147. PubMed ID: 34165436
[TBL] [Abstract][Full Text] [Related]
16. Glucose Induces IL-1α-Dependent Inflammation and Extracellular Matrix Proteins Expression and Deposition in Renal Tubular Epithelial Cells in Diabetic Kidney Disease.
Salti T; Khazim K; Haddad R; Campisi-Pinto S; Bar-Sela G; Cohen I
Front Immunol; 2020; 11():1270. PubMed ID: 32733443
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells.
Uthman L; Homayr A; Juni RP; Spin EL; Kerindongo R; Boomsma M; Hollmann MW; Preckel B; Koolwijk P; van Hinsbergh VWM; Zuurbier CJ; Albrecht M; Weber NC
Cell Physiol Biochem; 2019; 53(5):865-886. PubMed ID: 31724838
[TBL] [Abstract][Full Text] [Related]
18. Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis.
Elkazzaz SK; Khodeer DM; El Fayoumi HM; Moustafa YM
Life Sci; 2021 Sep; 280():119018. PubMed ID: 33549594
[TBL] [Abstract][Full Text] [Related]
19. Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.
Dekkers CCJ; Petrykiv S; Laverman GD; Cherney DZ; Gansevoort RT; Heerspink HJL
Diabetes Obes Metab; 2018 Aug; 20(8):1988-1993. PubMed ID: 29573529
[TBL] [Abstract][Full Text] [Related]
20. Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis.
Elsherbiny NM; Al-Gayyar MM; Abd El Galil KH
Life Sci; 2015 Dec; 143():8-17. PubMed ID: 26596562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
